Aptorum Group (Aptorum Group) Other Long-Term Liabilities : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Other Long-Term Liabilities?

Aptorum Group's other long-term liabilities for the quarter that ended in Jun. 2023 was $0.00 Mil.

Aptorum Group's quarterly other long-term liabilities increased from Jun. 2022 ($-0.00 Mil) to Dec. 2022 ($0.00 Mil) and increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($0.00 Mil).

Aptorum Group's annual other long-term liabilities increased from Dec. 2020 ($-0.00 Mil) to Dec. 2021 ($0.00 Mil) and increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).

Aptorum Group Other Long-Term Liabilities Historical Data

The historical data trend for Aptorum Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Other Long-Term Liabilities Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long-Term Liabilities

Get a 7-Day Free Trial

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Long-Term Liabilities	Get a 7-Day Free Trial							-	-	-	-	-

Aptorum Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Aptorum Group Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.